🇺🇸 FDA

Intelligence Platform

Patents

Browse 30 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9730962

Modalities for the treatment of degenerative diseases of the retina

Astellas Institute for Regenerative Medicine · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9650607

Modalities for the treatment of degenerative diseases of the retina

Astellas Institute for Regenerative Medicine · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9649340

Methods for producing enriched populations of human retinal pigment epithelium cells

Astellas Institute for Regenerative Medicine · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9617512

Derivation of embryonic stem cells and embryo-derived cells

Astellas Institute for Regenerative Medicine · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562217

Modalities for the treatment of degenerative diseases of the retina

Astellas Institute for Regenerative Medicine · Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9550974

Derivation of embryonic stem cells

Astellas Institute for Regenerative Medicine · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted